Upcoming Allied Market Research
Generic Injectable Market

Generic Injectable Market

Size, Share, Competitive Landscape and Trend Analysis Report by Product Type (Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Others), by Indication (Diabetes, Cancer, Cardiovascular Diseases, Infections, Others) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A11552
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


A generic injectable is a drug that has the same active pharmaceutical ingredient as its branded counterpart. A generic injectable is also equivalent to its branded counterpart in safety, strength, dosage form, performance, quality, and route of administration. Unlike branded injectable drugs, generic injectable has lower costs especially the ones used for cancer therapies. This is the reason why governments in many countries are focused on adopting generic injectable to help control healthcare spending. In addition, generic injectable has a high margin and low R&D investments.

COVID-19 Impact Analysis

  • COVID-19 is an infectious disease that originated in the Hubei province of Wuhan city in China in December 2019. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11th, 2020.
  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19.
  • However, the supply chain of raw materials required to manufacture generic injectables has been disrupted in many countries due to the pandemic. In addition, the market growth of generic injectables is also declining as manufacturers of these drugs have slowed down their production. This, in turn, is expected to have a significant impact on the generic injectable market.

Top Impacting Factors

  • With increase in drug shortage, especially in the U.S., governments in many countries are supporting the manufacture of generic injectable as they do not come with patents.
  • The rise in aging population and increase in cases of chronic diseases are also some of the factors that have led to shortage of injectable. This, in turn, helps to increase the demand for generic injectable.
  • The R&D cycles of generic drugs are shorter as they are the bio-equivalents of their branded counterparts. This offers the advantage of saving time to the manufacturers and is helps boost the growth of the generic injectable market.
  • The expiry of patents of branded injectable and less number of new launches are among the factors that have contributed to the growth of the generic injectable market.
  • However, the manufacturing of generic injectable is quite complex. With the lack of a skilled workforce in many developing countries, this can act as a restraint for the generic injectable market.

Key Market Trends

Major drug corporations across the world have keen interest to invest in generic injectable manufacturing facilities with the objective of cutting down corporate expense rates, improving manufacturing units, and building their presence in developing economies such as China and India.

In North America, the new duty changes in the U.S. have led to lower corporate taxes and aided pharmaceutical organizations to bolster their production capacities of generic injectable.

For instance, in 2020, an arrangement to contribute $465 million was reported by Pfizer, Inc. to fabricate an injectable plant in Michigan. This development is a part of Pfizer's plan to invest $5 billion in the U.S.-based capital tasks.

In the Asia-Pacific region, China is the leading producer of many pharmaceutical products, including generic injectable. China is experiencing dramatic increase in wages, making the manufacturing processes of pharmaceuticals quite expensive. Despite this, the Asia-Pacific region still remains to be one of the most affordable regions for pharmaceutical manufacturing.

In Europe, Germany has relatively strict regulatory guidelines for drug production and development. As a result, it is difficult to achieve approvals aimed at developing and producing new generic injectable. 

Key Benefits of the Report

  • This study presents the analytical depiction of the generic injectable market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the generic injectable market share.
  • The current market is quantitatively analyzed to highlight the generic injectable growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on the competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Generic Injectable Report

  • Which are the leading players active in the generic injectable market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the generic injectable market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 on the industry?
  • What is a generic injectable?
  • What are the current and predicted trends in the market?

Generic Injectable Market Report Highlights

Aspects Details
By Product Type
  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Vaccines
  • Others
By Indication
  • Diabetes
  • Cancer
  • Cardiovascular Diseases
  • Infections
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Drug Stores
  • Online Prescription Stores
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players Novartis AG (Sandoz), Baxter International, Johnson & Johnson, Pfizer, Inc., Bristol-Myers Squibb Company, AstraZeneca plc., GlaxoSmithKline Plc., Sanofi SA, Amgen Inc., Novo Nordisk A/S, Fresenius SE & Co. KGaA

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
Related Tags

Purchase Full Report of
Generic Injectable Market

Start reading.
This Report and over 71,297+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers